company background image
IART logo

Integra LifeSciences Holdings NasdaqGS:IART Stock Report

Last Price

US$34.24

Market Cap

US$2.7b

7D

-5.5%

1Y

-36.6%

Updated

18 Mar, 2024

Data

Company Financials +

Integra LifeSciences Holdings Corporation

NasdaqGS:IART Stock Report

Market Cap: US$2.7b

IART Stock Overview

Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical products, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology.

IART fundamental analysis
Snowflake Score
Valuation6/6
Future Growth4/6
Past Performance1/6
Financial Health3/6
Dividends0/6

Integra LifeSciences Holdings Corporation Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Integra LifeSciences Holdings
Historical stock prices
Current Share PriceUS$34.24
52 Week HighUS$59.33
52 Week LowUS$33.44
Beta1.13
1 Month Change-23.98%
3 Month Change-21.14%
1 Year Change-36.63%
3 Year Change-49.00%
5 Year Change-37.87%
Change since IPO640.32%

Recent News & Updates

Recent updates

Returns On Capital At Integra LifeSciences Holdings (NASDAQ:IART) Have Stalled

Feb 27
Returns On Capital At Integra LifeSciences Holdings (NASDAQ:IART) Have Stalled

We Think Integra LifeSciences Holdings (NASDAQ:IART) Can Stay On Top Of Its Debt

Feb 11
We Think Integra LifeSciences Holdings (NASDAQ:IART) Can Stay On Top Of Its Debt

Is Now An Opportune Moment To Examine Integra LifeSciences Holdings Corporation (NASDAQ:IART)?

Jan 14
Is Now An Opportune Moment To Examine Integra LifeSciences Holdings Corporation (NASDAQ:IART)?

Integra LifeSciences Holdings Corporation's (NASDAQ:IART) Price In Tune With Earnings

Dec 31
Integra LifeSciences Holdings Corporation's (NASDAQ:IART) Price In Tune With Earnings

Is Integra LifeSciences Holdings Corporation (NASDAQ:IART) Trading At A 46% Discount?

Dec 03
Is Integra LifeSciences Holdings Corporation (NASDAQ:IART) Trading At A 46% Discount?

Does Integra LifeSciences Holdings (NASDAQ:IART) Have A Healthy Balance Sheet?

Nov 06
Does Integra LifeSciences Holdings (NASDAQ:IART) Have A Healthy Balance Sheet?

Integra LifeSciences Holdings (NASDAQ:IART) Hasn't Managed To Accelerate Its Returns

Oct 24
Integra LifeSciences Holdings (NASDAQ:IART) Hasn't Managed To Accelerate Its Returns

Is Now An Opportune Moment To Examine Integra LifeSciences Holdings Corporation (NASDAQ:IART)?

Sep 22
Is Now An Opportune Moment To Examine Integra LifeSciences Holdings Corporation (NASDAQ:IART)?

Is Integra LifeSciences Holdings Corporation (NASDAQ:IART) Trading At A 38% Discount?

Aug 15
Is Integra LifeSciences Holdings Corporation (NASDAQ:IART) Trading At A 38% Discount?

Returns On Capital At Integra LifeSciences Holdings (NASDAQ:IART) Have Hit The Brakes

Jul 03
Returns On Capital At Integra LifeSciences Holdings (NASDAQ:IART) Have Hit The Brakes

Is There Now An Opportunity In Integra LifeSciences Holdings Corporation (NASDAQ:IART)?

Jun 19
Is There Now An Opportunity In Integra LifeSciences Holdings Corporation (NASDAQ:IART)?

Estimating The Fair Value Of Integra LifeSciences Holdings Corporation (NASDAQ:IART)

May 05
Estimating The Fair Value Of Integra LifeSciences Holdings Corporation (NASDAQ:IART)

These 4 Measures Indicate That Integra LifeSciences Holdings (NASDAQ:IART) Is Using Debt Reasonably Well

Apr 07
These 4 Measures Indicate That Integra LifeSciences Holdings (NASDAQ:IART) Is Using Debt Reasonably Well

Integra LifeSciences Holdings (NASDAQ:IART) Is Experiencing Growth In Returns On Capital

Mar 26
Integra LifeSciences Holdings (NASDAQ:IART) Is Experiencing Growth In Returns On Capital

At US$52.61, Is It Time To Put Integra LifeSciences Holdings Corporation (NASDAQ:IART) On Your Watch List?

Mar 14
At US$52.61, Is It Time To Put Integra LifeSciences Holdings Corporation (NASDAQ:IART) On Your Watch List?

Does Integra LifeSciences Holdings (NASDAQ:IART) Deserve A Spot On Your Watchlist?

Feb 27
Does Integra LifeSciences Holdings (NASDAQ:IART) Deserve A Spot On Your Watchlist?

Calculating The Fair Value Of Integra LifeSciences Holdings Corporation (NASDAQ:IART)

Feb 02
Calculating The Fair Value Of Integra LifeSciences Holdings Corporation (NASDAQ:IART)

We Think Integra LifeSciences Holdings (NASDAQ:IART) Can Stay On Top Of Its Debt

Jan 05
We Think Integra LifeSciences Holdings (NASDAQ:IART) Can Stay On Top Of Its Debt

Here's What To Make Of Integra LifeSciences Holdings' (NASDAQ:IART) Decelerating Rates Of Return

Dec 21
Here's What To Make Of Integra LifeSciences Holdings' (NASDAQ:IART) Decelerating Rates Of Return

When Should You Buy Integra LifeSciences Holdings Corporation (NASDAQ:IART)?

Dec 08
When Should You Buy Integra LifeSciences Holdings Corporation (NASDAQ:IART)?

Is Integra LifeSciences Holdings Corporation (NASDAQ:IART) Trading At A 42% Discount?

Oct 19
Is Integra LifeSciences Holdings Corporation (NASDAQ:IART) Trading At A 42% Discount?

We Think Integra LifeSciences Holdings (NASDAQ:IART) Can Stay On Top Of Its Debt

Oct 05
We Think Integra LifeSciences Holdings (NASDAQ:IART) Can Stay On Top Of Its Debt

Integra LifeSciences: Wide Dislocation In Fundamentals Vs. Market Value

Sep 13

Is It Time To Consider Buying Integra LifeSciences Holdings Corporation (NASDAQ:IART)?

Sep 06
Is It Time To Consider Buying Integra LifeSciences Holdings Corporation (NASDAQ:IART)?

FDA labels recall of intracranial pressure monitors by Integra as most serious

Aug 31

Integra Lifesciences voluntarily recalls pressure monitors, lowers revenue, profit guidance

Aug 24

Returns At Integra LifeSciences Holdings (NASDAQ:IART) Appear To Be Weighed Down

Aug 23
Returns At Integra LifeSciences Holdings (NASDAQ:IART) Appear To Be Weighed Down

Integra LifeSciences founder/former CEO dies

Aug 16

Integra LifeSciences Holdings GAAP EPS of $0.54 beats by $0.09, revenue of $398M beats by $2.62M

Jul 27

Is There An Opportunity With Integra LifeSciences Holdings Corporation's (NASDAQ:IART) 47% Undervaluation?

Jul 20
Is There An Opportunity With Integra LifeSciences Holdings Corporation's (NASDAQ:IART) 47% Undervaluation?

These 4 Measures Indicate That Integra LifeSciences Holdings (NASDAQ:IART) Is Using Debt Reasonably Well

Jul 07
These 4 Measures Indicate That Integra LifeSciences Holdings (NASDAQ:IART) Is Using Debt Reasonably Well

Is It Time To Consider Buying Integra LifeSciences Holdings Corporation (NASDAQ:IART)?

May 24
Is It Time To Consider Buying Integra LifeSciences Holdings Corporation (NASDAQ:IART)?

Integra LifeSciences Holdings (NASDAQ:IART) Has Some Way To Go To Become A Multi-Bagger

May 09
Integra LifeSciences Holdings (NASDAQ:IART) Has Some Way To Go To Become A Multi-Bagger

Shareholder Returns

IARTUS Medical EquipmentUS Market
7D-5.5%-1.4%0.5%
1Y-36.6%11.9%29.0%

Return vs Industry: IART underperformed the US Medical Equipment industry which returned 12.2% over the past year.

Return vs Market: IART underperformed the US Market which returned 28.4% over the past year.

Price Volatility

Is IART's price volatile compared to industry and market?
IART volatility
IART Average Weekly Movement5.4%
Medical Equipment Industry Average Movement8.0%
Market Average Movement6.0%
10% most volatile stocks in US Market16.8%
10% least volatile stocks in US Market3.0%

Stable Share Price: IART's share price has been volatile over the past 3 months.

Volatility Over Time: IART's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19893,946Jan De Wittehttps://www.integralife.com

Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical products, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as after-market services.

Integra LifeSciences Holdings Corporation Fundamentals Summary

How do Integra LifeSciences Holdings's earnings and revenue compare to its market cap?
IART fundamental statistics
Market capUS$2.68b
Earnings (TTM)US$67.74m
Revenue (TTM)US$1.54b

39.5x

P/E Ratio

1.7x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
IART income statement (TTM)
RevenueUS$1.54b
Cost of RevenueUS$593.66m
Gross ProfitUS$947.92m
Other ExpensesUS$880.18m
EarningsUS$67.74m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)0.87
Gross Margin61.49%
Net Profit Margin4.39%
Debt/Equity Ratio94.6%

How did IART perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.